Literature DB >> 20921245

Herpes zoster and postherpetic neuralgia.

C Peter N Watson1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20921245      PMCID: PMC2972317          DOI: 10.1503/cmaj.101409

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study.

Authors:  Mélanie Drolet; Marc Brisson; Kenneth E Schmader; Myron J Levin; Robert Johnson; Michael N Oxman; David Patrick; Caty Blanchette; James A Mansi
Journal:  CMAJ       Date:  2010-10-04       Impact factor: 8.262

Review 2.  Combination pharmacotherapy for neuropathic pain: current evidence and future directions.

Authors:  Ian Gilron; Mitchell B Max
Journal:  Expert Rev Neurother       Date:  2005-11       Impact factor: 4.618

Review 3.  Herpes zoster and postherpetic neuralgia: past, present and future.

Authors:  Gary J Bennett; C Peter N Watson
Journal:  Pain Res Manag       Date:  2009 Jul-Aug       Impact factor: 3.037

4.  The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia.

Authors:  Marc Brisson; James M Pellissier; Stéphanie Camden; Caroline Quach; Philippe De Wals
Journal:  Hum Vaccin       Date:  2010-05-25

5.  Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society.

Authors:  D E Moulin; A J Clark; I Gilron; M A Ware; C P N Watson; B J Sessle; T Coderre; P K Morley-Forster; J Stinson; A Boulanger; P Peng; G A Finley; P Taenzer; P Squire; D Dion; A Cholkan; A Gilani; A Gordon; J Henry; R Jovey; M Lynch; A Mailis-Gagnon; A Panju; G B Rollman; A Velly
Journal:  Pain Res Manag       Date:  2007       Impact factor: 3.037

6.  A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Authors:  M N Oxman; M J Levin; G R Johnson; K E Schmader; S E Straus; L D Gelb; R D Arbeit; M S Simberkoff; A A Gershon; L E Davis; A Weinberg; K D Boardman; H M Williams; J Hongyuan Zhang; P N Peduzzi; C E Beisel; V A Morrison; J C Guatelli; P A Brooks; C A Kauffman; C T Pachucki; K M Neuzil; R F Betts; P F Wright; M R Griffin; P Brunell; N E Soto; A R Marques; S K Keay; R P Goodman; D J Cotton; J W Gnann; J Loutit; M Holodniy; W A Keitel; G E Crawford; S-S Yeh; Z Lobo; J F Toney; R N Greenberg; P M Keller; R Harbecke; A R Hayward; M R Irwin; T C Kyriakides; C Y Chan; I S F Chan; W W B Wang; P W Annunziato; J L Silber
Journal:  N Engl J Med       Date:  2005-06-02       Impact factor: 91.245

7.  Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors.

Authors:  Peng-Jun Lu; Gary L Euler; Aisha O Jumaan; Rafael Harpaz
Journal:  Vaccine       Date:  2008-12-09       Impact factor: 3.641

Review 8.  Antiviral treatment for preventing postherpetic neuralgia.

Authors:  Qifu Li; Ning Chen; Jie Yang; Muke Zhou; Dong Zhou; Quanwei Zhang; Li He
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.